Adjarai, Al-furqan .

HRN: 26-69-21  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/27/2026
07/04/2026
IV
690mg
Q6h
Uti
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines